Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro-Reference-Cited by-同舟云学术

Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro

Published:2016-01 Issue:1 Volume:214 Page:99.e1-99.e8
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Bellone Stefania,Black Jonathan,English Diana P.,Schwab Carlton L.,Lopez Salvatore,Cocco Emiliano,Bonazzoli Elena,Predolini Federica,Ferrari Francesca,Ratner Elena,Silasi Dan-Arin,Azodi Masoud,Schwartz Peter E.,Santin Alessandro D.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference27 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma;Hendrickson;Am J Surg Pathol,1982

3. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases;Slomovitz;Gynecol Oncol,2003

4. Uterine papillary serous carcinoma: patterns of metastatic spread;Goff;Gynecol Oncol,1994

5. Endometrial papillary serous carcinoma: patterns of spread and treatment;Nicklin;Clin Obstet Gynecol,1996

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colorectal Cancer Stem Cells and Targeted Agents;Pharmaceutics;2023-12-12

2. The past, present, and future of immunotherapy for endometrial adenocarcinoma;Medical Oncology;2023-05-23

3. Facts and Hopes in Immunotherapy of Endometrial Cancer;Clinical Cancer Research;2022-07-05

4. Enabling the next steps in cancer immunotherapy: from antibody-based bispecifics to multispecifics, with an evolving role for bioconjugation chemistry;RSC Chemical Biology;2022

5. The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors;International Journal of Molecular Sciences;2021-10-21